Chime Biologics Announced the Expansion of GMP Manufacturing Capacity with Construction of a Second GMP Facility (GMP-2)

Chime Biologics Achieved a Milestone Leap by Completion of Process Performance Verification with High Quality and Efficiency

Chime Biologics has Signed a Contract with Wuhan East Lake High-tech Zone of Investing $900 Million to Build the World’s Most Competitive Biomedical CDMO Commercial Base

categoryidArraymk-test